Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases
You-Jung Shin, Ji-Young Kim, Jei-Won Moon, Rae-Mi You, Jeong-Yeol Park, Joo-Hyun Nam
Cancer Res Treat. 2011;43(4):260-263.   Published online 2011 Dec 27     DOI: https://doi.org/10.4143/crt.2011.43.4.260
Citations to this article as recorded by Crossref logo
Incidence et facteurs de risque de l’encéphalopathie à l’ifosfamide chez les patients suivis pour un sarcome
Natacha Stern, Ilyes Sakji, Anne-Sophie Defachelles, Cyril Lervat, Thomas Ryckewaert, Guillaume Marliot, Charlotte Peugniez, Dominique Deplanque, Nicolas Penel
Bulletin du Cancer.2017; 104(3): 208.     CrossRef
Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: A retrospective analysis
Yin Lo, Li-Jiuan Shen, Wen-Hwei Chen, Yaa-Hui Dong, Fe-Lin Lin Wu
Journal of the Formosan Medical Association.2016; 115(9): 744.     CrossRef
Ifosfamide related encephalopathy: The need for a timely EEG evaluation
Anteneh M. Feyissa, Sudhakar Tummala
Journal of the Neurological Sciences.2014; 336(1-2): 109.     CrossRef
PharmGKB summary
Daniella Lowenberg, Caroline F. Thorn, Zeruesenay Desta, David A. Flockhart, Russ B. Altman, Teri E. Klein
Pharmacogenetics and Genomics.2014; 24(2): 133.     CrossRef